133 related articles for article (PubMed ID: 17636011)
1. Simvastatin protects against multiple low-dose streptozotocin-induced type 1 diabetes in CD-1 mice and recurrence of disease in nonobese diabetic mice.
Rydgren T; Vaarala O; Sandler S
J Pharmacol Exp Ther; 2007 Oct; 323(1):180-5. PubMed ID: 17636011
[TBL] [Abstract][Full Text] [Related]
2. The protective effect of simvastatin against low dose streptozotocin induced type 1 diabetes in mice is independent of inhibition of HMG-CoA reductase.
Rydgren T; Sandler S
Biochem Biophys Res Commun; 2009 Feb; 379(4):1076-9. PubMed ID: 19150339
[TBL] [Abstract][Full Text] [Related]
3. Newly weaned nonobese diabetic mice show heightened early diabetes sensitivity to multiple low doses of streptozotocin than nondiabetes-prone CD-1 mice: initial beta-cell damage a key trigger for type 1 diabetes?
Reddy S; Elliott RB; Chang M; Hsu T; Rodrigues JA; Qiao L; Robinson E
Pancreas; 2008 Jul; 37(1):e8-e19. PubMed ID: 18580436
[TBL] [Abstract][Full Text] [Related]
4. Young NOD mice show increased diabetes sensitivity to low doses of streptozotocin.
Reddy S; Chang M; Robinson E
Ann N Y Acad Sci; 2006 Oct; 1079():109-13. PubMed ID: 17130539
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
[TBL] [Abstract][Full Text] [Related]
6. Methadone ameliorates multiple-low-dose streptozotocin-induced type 1 diabetes in mice.
Amirshahrokhi K; Dehpour AR; Hadjati J; Sotoudeh M; Ghazi-Khansari M
Toxicol Appl Pharmacol; 2008 Oct; 232(1):119-24. PubMed ID: 18671992
[TBL] [Abstract][Full Text] [Related]
7. Preventative effects of the flowers of Inula britannica on autoimmune diabetes in C57BL/KsJ mice induced by multiple low doses of streptozotocin.
Kobayashi T; Song QH; Hong T; Kitamura H; Cyong JC
Phytother Res; 2002 Jun; 16(4):377-82. PubMed ID: 12112297
[TBL] [Abstract][Full Text] [Related]
8. NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes.
Yasuda H; Jin Z; Nakayama M; Yamada K; Kishi M; Okumachi Y; Arai T; Moriyama H; Yokono K; Nagata M
Diabetes Res Clin Pract; 2009 Feb; 83(2):200-7. PubMed ID: 19117633
[TBL] [Abstract][Full Text] [Related]
9. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice.
Fukudome D; Matsuda M; Kawasaki T; Ago Y; Matsuda T
Eur J Pharmacol; 2008 Mar; 583(1):164-9. PubMed ID: 18291360
[TBL] [Abstract][Full Text] [Related]
10. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
11. Statin pre-treatment protects brain against focal cerebral ischemia in diabetic mice.
Cakmak A; Yemişçi M; Köksoy C; Yazgan U; Dinçer D; Dalkara T
J Surg Res; 2007 Apr; 138(2):254-8. PubMed ID: 17275846
[TBL] [Abstract][Full Text] [Related]
12. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
Malmström RE; Settergren M; Böhm F; Pernow J; Hjemdahl P
Thromb Haemost; 2009 Jan; 101(1):157-64. PubMed ID: 19132203
[TBL] [Abstract][Full Text] [Related]
13. [Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice].
Zhang S; Yan X; Zhou PC; Huang C; Yang L; Li X; Lin J; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):568-72. PubMed ID: 18649776
[TBL] [Abstract][Full Text] [Related]
14. Inosine protects against the development of diabetes in multiple-low-dose streptozotocin and nonobese diabetic mouse models of type 1 diabetes.
Mabley JG; Rabinovitch A; Suarez-Pinzon W; Haskó G; Pacher P; Power R; Southan G; Salzman A; Szabó C
Mol Med; 2003; 9(3-4):96-104. PubMed ID: 12865945
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with epidermal growth factor and gastrin delays autoimmune diabetes recurrence in nonobese diabetic mice transplanted with syngeneic islets.
Suarez-Pinzon WL; Rabinovitch A
Transplant Proc; 2008 Mar; 40(2):529-32. PubMed ID: 18374121
[TBL] [Abstract][Full Text] [Related]
16. IL-23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin.
Mensah-Brown EP; Shahin A; Al-Shamisi M; Wei X; Lukic ML
Eur J Immunol; 2006 Jan; 36(1):216-23. PubMed ID: 16358360
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin gene-related peptide gene therapy suppresses reactive oxygen species in the pancreas and prevents mice from autoimmune diabetes.
She F; Sun W; Mao JM; Wang X
Sheng Li Xue Bao; 2003 Dec; 55(6):625-32. PubMed ID: 14695477
[TBL] [Abstract][Full Text] [Related]
18. The effect of simvastatin on coenzyme Q and antioxidant/oxidant balance in diabetic-hypercholesterolaemic rats.
Kuzelová M; Adameová A; Sumbalová Z; Paulíková I; Harcárová A; Svec P; Kucharská J
Gen Physiol Biophys; 2008 Dec; 27(4):291-8. PubMed ID: 19202203
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Stosic-Grujicic S; Stojanovic I; Maksimovic-Ivanic D; Momcilovic M; Popadic D; Harhaji L; Miljkovic D; Metz C; Mangano K; Papaccio G; Al-Abed Y; Nicoletti F
J Cell Physiol; 2008 Jun; 215(3):665-75. PubMed ID: 18064633
[TBL] [Abstract][Full Text] [Related]
20. Streptozotocin diabetes in juvenile pigs. Evaluation of an experimental model.
Gäbel H; Bitter-Suermann H; Henriksson C; Säve-Söderbergh J; Lundholm K; Brynger H
Horm Metab Res; 1985 Jun; 17(6):275-80. PubMed ID: 3160643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
